This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 13;59(11):1039-40; author reply 1040-1.

doi: 10.1016/j.jacc.2011.11.041.

Antiarrhythmic drug therapy in 2012: time to finally open our eyes!

Michele Coceani

PMID: 22402080
DOI: 10.1016/j.jacc.2011.11.041

Free article

Comment

Antiarrhythmic drug therapy in 2012: time to finally open our eyes!

Michele Coceani. J Am Coll Cardiol. 2012.

Free article

. 2012 Mar 13;59(11):1039-40; author reply 1040-1.

doi: 10.1016/j.jacc.2011.11.041.

Author

Michele Coceani

PMID: 22402080
DOI: 10.1016/j.jacc.2011.11.041

No abstract available

PubMed Disclaimer

Comment on

Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
Saksena S, Slee A, Waldo AL, Freemantle N, Reynolds M, Rosenberg Y, Rathod S, Grant S, Thomas E, Wyse DG. Saksena S, et al. J Am Coll Cardiol. 2011 Nov 1;58(19):1975-85. doi: 10.1016/j.jacc.2011.07.036. J Am Coll Cardiol. 2011. PMID: 22032709 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information